Companies: 10,795·Total market cap: $144.5T
NexgenRx Inc.

NexgenRx Inc.

NEGXFOTCHealthcare● Active
$0.27
+$0.00(+0.00%)
Market Cap$19201626
P/E Ratio
52W High$0.28
52W Low$0.19

NexgenRx Inc. (NEGXF) Revenue

Annual & quarterly revenue history · segment & region breakdown

NEGXF · revenue · updated Jun 9, 2026

Core revenue metrics

NexgenRx Inc. trailing twelve-month (TTM) revenue is $0.02B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.02B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
0.78×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$917K
20 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · NexgenRx Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
NEGXF revenue by year · NEGXF revenue history · NEGXF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income NexgenRx Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

NexgenRx Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from NexgenRx Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

NEGXF revenue · 4 questions

NEGXF's trailing twelve-month (TTM) revenue is $0.02B. That is an increase of 0.00% year-over-year from — in FY.

NEGXF revenueNEGXF annual revenuewhat is NEGXF revenueNEGXF TTM revenue

Source: FMP · NexgenRx Inc. SEC filings · GAAP · NexgenRx Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026